A Real-world Study Comparing the Effectiveness of Ofatumumab and Ocrelizumab Treatment in Multiple Sclerosis Patients
Clinical trial NCT07566988 · COMPLETED
Trial details
- NCT number
- NCT07566988
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2024-10-25
- Primary completion
- 2025-04-30
- Enrollment
- 2604
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.